Noom: AI & GLP-1 for Chronic Disease Management
- Noom is combining GLP-1 medications with its behavior change platform to create a more affordable and effective healthcare solution.
- New initiatives include partnerships to lower GLP-1 medication costs and an AI body scan that measures lean muscle and fat composition.
- Wearable tech and AI are being leveraged to personalize health interventions and prevent muscle loss,addressing future health risks such as sarcopenia.
Noom champions a new approach to chronic disease management,merging GLP-1 medications wiht its behaviour change platform for improved outcomes. The company leverages AI body scans to personalize health plans and reduce the cost of medications, empowering users with a lasting and accessible healthcare solution. CEO Geoff Cook and Chief Commercial Officer Cody fair highlight the critical role of behavior change and data-driven insights in achieving thes goals. They aim to offer end-to-end weight management solutions.Noom embraces democratizing healthcare integrating medication,coaching,and data. News Directory 3 keeps readers informed on these developments. What’s next for this exciting new platform? Discover what’s next for accessible solutions.
Noom Integrates GLP-1 Meds with Behavior Change Platform for Weight Management
Updated June 19, 2025
Noom is combining GLP-1 medications with its behavior change platform to create a more affordable and effective healthcare solution. Geoff Cook, CEO, and Cody Fair, chief commercial officer, said the company aims to help people live healthier and longer lives through accessible healthcare solutions and behavior change.
New initiatives include partnerships to lower GLP-1 medication costs and an AI body scan that measures lean muscle and fat composition. This empowers employers to offer sustainable health benefits, even with high-cost medications. Cook and Fair emphasized the critical role of behavior change, highlighting protein tracking and AI-powered food logging to improve outcomes.
Wearable tech and AI are being leveraged to personalize health interventions and prevent muscle loss,addressing future health risks such as sarcopenia. The company also stresses the importance of democratizing healthcare by offering end-to-end solutions that integrate medication, coaching, and data-driven insights for chronic disease management. This approach to weight management aims to make healthcare more accessible and affordable.
What’s next
Noom plans to continue expanding its integrated platform, focusing on personalized interventions and accessible solutions for chronic disease management, further solidifying its role in the evolving landscape of healthcare.